Anteris Technologies Global (AVR) Stock Price, News & Analysis

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Key Stats

• Today's Range: $9.03 to $9.79
• 50-Day Range: $5.11 to $9.62
• 52-Week Range: $2.85 to $9.79
• Volume: 2.35 million shs
• Average Volume: 963,383 shs
• Market Capitalization: $936.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.00
• Consensus Rating: Moderate Buy

Anteris Technologies Global Stock Analysis - MarketRank™

Anteris Technologies Global scored higher than 62% of companies evaluated by MarketBeat, and ranked 324th out of 867 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Anteris Technologies Global has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Anteris Technologies Global has a consensus price target of $16.00, representing about 66.3% upside from its current price of $9.62.

Amount of Analyst Coverage

Anteris Technologies Global has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Anteris Technologies Global are expected to grow in the coming year, from ($1.14) to ($0.99) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Anteris Technologies Global is -4.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Anteris Technologies Global is -4.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Anteris Technologies Global has a P/B Ratio of 3.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.03% of the float of Anteris Technologies Global has been sold short.

Short Interest Ratio / Days to Cover

Anteris Technologies Global has a short interest ratio ("days to cover") of 5.22.

Change versus previous month

Short interest in Anteris Technologies Global has recently decreased by 9.46%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Anteris Technologies Global does not currently pay a dividend.

Dividend Growth

Anteris Technologies Global does not have a long track record of dividend growth.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: -0.20

News Sentiment

Anteris Technologies Global has a news sentiment score of -0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Anteris Technologies Global this week, compared to 3 articles on an average week.

Search Interest

2 people have searched for AVR on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

3 people have added Anteris Technologies Global to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Anteris Technologies Global insiders have not sold or bought any company stock.

Percentage Held by Insiders

4.50% of the stock of Anteris Technologies Global is held by insiders.

Percentage Held by Institutions

Anteris Technologies Global has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/12/2026
• Today: 5/26/2026
• Next Earnings (Estimated): 8/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AVR
• Previous Symbol: NASDAQ:AVR
• CIK: 2011514
• Web: N/A
• Phone: (651) 493-0606
• Fax: N/A
• Employees: 138
• Year Founded: 2024

Price Target and Rating

• Average Price Target for Anteris Technologies Global: $16.00
• High Price Target: $18.00
• Low Price Target: $15.00
• Potential Upside/Downside: +66.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.60
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$94.14 million
• Net Margins: -5,148.78%
• Pretax Margin: -5,116.15%
• Return on Equity: -124.76%
• Return on Assets: -101.21%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 20.93
• Quick Ratio: 20.93

Sales & Book Value

• Annual Sales: $1.91 million
• Price / Sales: 490.27
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.86 per share
• Price / Book: 3.36

Miscellaneous

• Outstanding Shares: 97,340,000
• Free Float: 92,962,000
• Market Cap: $936.41 million
• Optionable: N/A
• Beta: 1.32